Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-14-001924
Filing Date
2014-06-16
Accepted
2014-06-16 17:14:25
Documents
10
Period of Report
2014-04-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT form10q.htm 10-Q 433417
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 8914
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 8960
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6785
  Complete submission text file 0001493152-14-001924.txt   3627736

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cgnh-20140430.xml EX-101.INS 412994
6 XBRL SCHEMA FILE cgnh-20140430.xsd EX-101.SCH 44979
7 XBRL CALCULATION FILE cgnh-20140430_cal.xml EX-101.CAL 66171
8 XBRL DEFINITION FILE cgnh-20140430_def.xml EX-101.DEF 115750
9 XBRL LABEL FILE cgnh-20140430_lab.xml EX-101.LAB 291117
10 XBRL PRESENTATION FILE cgnh-20140430_pre.xml EX-101.PRE 221179
Mailing Address 6295 NORTHAM DRIVE, UNIT 8 MISSISSAUGA, A6 L4V 1W8
Business Address 6865 SW 18TH STREET SUITE B13 BACA RATON FL 33433 905.673.8501
CardioGenics Holdings Inc. (Filer) CIK: 0001089029 (see all company filings)

EIN.: 880380456 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28761 | Film No.: 14923521
SIC: 7389 Services-Business Services, NEC